While the new generations of antibiotics have emerged, some older antibiotics are still important in modern medical practice.
One of them is aminoglycoside antibiotic, which is commonly prescribed in the management of serious bacterial infections because of its effectiveness in treating Gram-negative bacteria. The use of these antibiotics will help the aminoglycosides market grow steadily.
It is important to note that aminoglycosides are mostly administered through combinations with other drugs, but they are important in dealing with infections requiring the rapid elimination of bacteria.
Effectiveness in Treating Serious Bacterial Infections
Aminoglycosides are effective against many species of Gram-negative bacteria. They are very helpful in treating potentially lethal infections, such as sepsis and infections acquired in hospitals.
The use of aminoglycosides has become common in ICUs to treat bloodstream infections, where rapid action is required.
Use in Combination Regimens
Another reason why aminoglycosides are still in use today is that they are very efficient when used in combination with other medications. Combination therapy allows not only increasing the efficacy but also minimizing the chances of developing antibiotic resistance.
For instance, aminoglycosides are commonly used in conjunction with beta-lactam antibiotics to treat complicated infections. It is especially effective in treating endocarditis due to its synergistic effect.
Growing Problem of Antimicrobial Resistance
The rising problem of antimicrobial resistance is one of the factors affecting the ongoing use of antibiotics. Sometimes, established medications, such as aminoglycosides, are the only available options to combat multidrug resistance.
For example, aminoglycosides can be used as targeted therapy to tackle multidrug resistance in bacterial infections. As such, they are essential to address the current health issues in the area of infectious diseases.
Ongoing Use in Clinical Practice
Aminoglycosides are popular medications in hospitals, primarily in intensive care units. Due to their fast action and efficiency, aminoglycosides can be prescribed in acute cases and when there is no time to wait for the test results.
